Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Learn more about our Recombinant Proteins
has received contract grant funding from Acadia Pharmaceuticals, Lundbeck, Takeda and Axovant pharmaceutical companies, as well as honoraria from Lundbeck, Lilly, Otsuka and Orion pharmaceutical companies
Laparoscopic resection of an adrenal schwannoma
118 In ER/HER2 breast cancer, hyperactivated AKT1 binds to the kinase domain of TBK1, disrupting the STING-TBK1-IRF3 complex, thereby impairing downstream interferon signaling and blocking innate immune responses triggered by DNA damage
US$ 25.30
US$ 23.95
US$ 20.33
US$ 25.13
US$ 24.64
